Screener
Iovance Biotherapeutics, Inc. IOVA Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Iovance Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
FAQ
- What is Iovance Biotherapeutics, Inc.'s net margin?
- Iovance Biotherapeutics, Inc. (IOVA) reported net margin of -89.1% in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s net margin changed year-over-year?
- Iovance Biotherapeutics, Inc.'s net margin increased by 44.8% year-over-year, from -161.4% to -89.1%.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s net margin?
- Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s net margin has grown at a -93.7% compound annual growth rate (CAGR), from -37,345.4% to -148.4%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Iovance Biotherapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude